Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0752 SEK | -5.41% | -13.96% | -78.70% |
04-05 | Diagonal Bio AB Announces the Extension of Its Partnership with Horsholm Veterinary Clinic | CI |
04-05 | Diagonal Bio AB Announces Successful Pilot Study Results | CI |
Sales 2021 | 8.67M 793K 63.44M | Sales 2022 | 3.71M 339K 27.12M | Capitalization | 10.06M 920K 73.64M |
---|---|---|---|---|---|
Net income 2021 | -11M -1.01M -80.49M | Net income 2022 | -16M -1.46M -117M | EV / Sales 2021 | 7.06 x |
Net cash position 2021 | 20.77M 1.9M 152M | Net cash position 2022 | 13.58M 1.24M 99.4M | EV / Sales 2022 | -0.95 x |
P/E ratio 2021 |
-5.28
x | P/E ratio 2022 |
-0.65
x | Employees | 4 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.26% |
1 day | -5.41% | ||
1 week | -13.96% | ||
Current month | -14.74% | ||
1 month | -11.22% | ||
3 months | -72.10% | ||
6 months | -83.21% | ||
Current year | -78.70% |
Managers | Title | Age | Since |
---|---|---|---|
Karin Wehlin
CEO | Chief Executive Officer | - | 02-27 |
Andreas Nyberg
FOU | Founder | 48 | 18/03/20 |
Director of Finance/CFO | 60 | 31/12/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eva Nilsagård
CHM | Chairman | 60 | 31/12/20 |
Director/Board Member | 68 | 31/12/20 | |
Director/Board Member | 39 | 31/12/20 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.0752 | -5.41% | 710,543 |
25/04/24 | 0.0795 | -2.45% | 793,770 |
24/04/24 | 0.0815 | -9.34% | 792,550 |
23/04/24 | 0.0899 | -2.28% | 207,402 |
22/04/24 | 0.092 | +5.26% | 525,756 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 04:23 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-78.70% | 2.75M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- DIABIO Stock